Amundi cut its stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 34.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 674,423 shares of the company's stock after selling 362,234 shares during the period. Amundi owned approximately 0.35% of Docusign worth $29,958,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in DOCU. Modus Advisors LLC purchased a new stake in shares of Docusign during the 4th quarter worth about $27,000. Cary Street Partners Investment Advisory LLC increased its stake in shares of Docusign by 309.5% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 561 shares of the company's stock worth $38,000 after purchasing an additional 424 shares during the last quarter. Basepoint Wealth LLC bought a new position in shares of Docusign during the 4th quarter valued at $39,000. WealthCollab LLC raised its holdings in shares of Docusign by 372.4% during the 1st quarter. WealthCollab LLC now owns 855 shares of the company's stock valued at $41,000 after purchasing an additional 674 shares in the last quarter. Finally, Virtus Advisers LLC acquired a new stake in shares of Docusign in the second quarter worth about $47,000. 77.64% of the stock is currently owned by institutional investors and hedge funds.
Trending Headlines about Docusign
Here are the key news stories impacting Docusign this week:
- Positive Sentiment: Docusign reported quarterly earnings and revenue above analyst estimates, while revenue grew 9.4% year over year. Management also highlighted margin gains, stronger cash flow and continued IAM adoption. Docusign Declines After Beating Q2 Earnings and Revenue Estimates
- Positive Sentiment: The IAM platform now represents 15.1% of annual recurring revenue, suggesting Docusign is using AI to expand beyond traditional electronic signatures and potentially increase customer value. Docusign Q2 2027 Earnings Call Transcript
- Positive Sentiment: Docusign and Stephen Curry’s UNDERRATED Golf announced a “Where Deals Get Done” partnership. The marketing agreement may support brand visibility, although its direct financial impact was not disclosed. Stephen Curry's UNDERRATED Golf and Docusign Partnership
- Neutral Sentiment: Reported short interest was zero shares, indicating little evidence of an active short-selling position or near-term short-squeeze potential.
- Negative Sentiment: DOCU declined despite the earnings and revenue beat, suggesting investors may have already priced in the strong results or remain cautious about the pace of IAM adoption and future growth. Docusign Declines After Earnings Beat
- Negative Sentiment: Director Peter Solvik sold 46,000 shares worth approximately $3.0 million, reducing his holdings by 48.14%. Director Teresa Briggs also sold shares, though her transaction was executed under a pre-arranged Rule 10b5-1 plan. These sales can weigh on sentiment, even though they do not necessarily signal deteriorating fundamentals.
Wall Street Analysts Forecast Growth
DOCU has been the subject of several recent analyst reports. Piper Sandler increased their target price on Docusign from $52.00 to $75.00 and gave the company a "neutral" rating in a research note on Friday, September 4th. Jefferies Financial Group increased their price target on shares of Docusign from $45.00 to $50.00 and gave the stock a "hold" rating in a research report on Friday, June 5th. Weiss Ratings upgraded shares of Docusign from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, August 25th. Bank of America lifted their price objective on Docusign from $58.00 to $64.00 and gave the company an "underperform" rating in a report on Friday, September 4th. Finally, Wells Fargo & Company upped their price target on Docusign from $55.00 to $60.00 and gave the company an "equal weight" rating in a research report on Friday, September 4th. Three investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $67.33.
Get Our Latest Analysis on Docusign
Docusign Stock Performance
Shares of NASDAQ DOCU opened at $65.65 on Friday. Docusign Inc. has a 52 week low of $40.16 and a 52 week high of $86.65. The stock has a 50 day moving average price of $57.75 and a 200 day moving average price of $50.61. The stock has a market capitalization of $12.27 billion, a PE ratio of 40.03, a price-to-earnings-growth ratio of 2.48 and a beta of 0.90.
Docusign (NASDAQ:DOCU - Get Free Report) last released its quarterly earnings results on Thursday, September 3rd. The company reported $1.16 EPS for the quarter, beating the consensus estimate of $1.09 by $0.07. Docusign had a net margin of 9.82% and a return on equity of 18.29%. The business had revenue of $875.75 million for the quarter, compared to the consensus estimate of $867.22 million. During the same period in the prior year, the company posted $0.30 earnings per share. Docusign's revenue was up 9.4% compared to the same quarter last year. As a group, research analysts forecast that Docusign Inc. will post 2.1 EPS for the current year.
Insider Buying and Selling
In other Docusign news, Director James A. Beer sold 450 shares of the company's stock in a transaction dated Friday, August 28th. The shares were sold at an average price of $64.02, for a total value of $28,809.00. Following the completion of the sale, the director directly owned 14,586 shares of the company's stock, valued at approximately $933,795.72. This represents a 2.99% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Blake Grayson sold 15,000 shares of the firm's stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $65.57, for a total value of $983,550.00. Following the completion of the sale, the chief financial officer directly owned 81,429 shares of the company's stock, valued at $5,339,299.53. This represents a 15.56% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 182,150 shares of company stock worth $10,443,740. Corporate insiders own 0.59% of the company's stock.
Docusign Company Profile
(
Free Report)
DocuSign, Inc is a provider of digital agreement management and electronic signature solutions. Its platform enables individuals and organizations to prepare, send, sign, manage and store agreements electronically, helping businesses replace paper-based contracting processes with digital workflows.
The company's products and services include DocuSign eSignature, which supports electronic signing and authentication, as well as tools for contract lifecycle management, agreement preparation, identity verification, notarial services and workflow automation.
Featured Stories
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.